Traws Pharma Inc (TRAW)

[Invest-in-America]

TRAW: I saw TRAW --- which spells WART, backwards --- yesterday (Post-M) at the top of my daily Post-M data source, as follows:
https://www.tradingview.com/markets/stocks-usa/market-movers-after-hours-gainers/
However, conspicuously MISSING from their PR is any beneficial EFFECT (if any) upon the Phase-1 trial SUBJECTS themselves --- other than the typical jargon about "safety" & "adverse effects". (I.e., a FLUFFY PR, at best.) Nevertheless, I may indeed toss BUCKS at it anyway, since we ALL know Wall Street is about making MONEY, and NOT nit-picking news nor PR's, RIGHT???)
////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
TRAW (3.7-Mil. Flt., 0.1%): $8.06, 58%-Up; XXX ; (Post-M) news Bird Flu, Phase-1; Virology & Oncology, Penn.